
    
      The investigators will test the validity of biomarkers for the detection of heavy alcohol use
      in patients with and without liver disease.

      The investigators will test the validity of carbohydrate deficient transferrin (CDT)(using
      capillary zone electrophoresis) in blood and ethyl glucuronide (EtG)(using Liquid
      Chromatography-MS-MS) in hair in patients with heavy alcohol use, moderate alcohol use and
      patients who do not drink alcohol.
    
  